Free Trial

CME Group (NASDAQ:CME) Stock Unloaded Rep. Jefferson Shreve

CME Group logo with Finance background

Representative Jefferson Shreve (R-Indiana) recently sold shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $15,001 and $50,000 in CME Group stock on May 12th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of Hubbell NYSE: HUBB on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Trane Technologies NYSE: TT on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of RTX NYSE: RTX on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of NiSource NYSE: NI on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Johnson & Johnson NYSE: JNJ on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of AppLovin NASDAQ: APP on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of Fiserv NYSE: FI on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of CNO Financial Group NYSE: CNO on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Cboe Global Markets NASDAQ: CBOE on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 5/12/2025.

CME Group Stock Up 0.9%

Shares of CME traded up $2.37 on Friday, hitting $279.55. 1,834,736 shares of the stock traded hands, compared to its average volume of 2,117,443. CME Group Inc. has a one year low of $193.25 and a one year high of $290.79. The company has a market capitalization of $100.74 billion, a PE ratio of 27.06, a P/E/G ratio of 4.85 and a beta of 0.44. The business has a 50 day simple moving average of $276.44 and a 200 day simple moving average of $262.25. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. CME Group's revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.56 EPS. As a group, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.79%. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Oppenheimer raised their target price on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday. Bank of America increased their target price on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Morgan Stanley increased their target price on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Finally, Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $261.93.

View Our Latest Report on CME

Insider Activity at CME Group

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the transaction, the director directly owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the transaction, the director directly owned 4,900 shares of the company's stock, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,400 shares of company stock worth $3,152,410 in the last three months. Company insiders own 0.30% of the company's stock.

Institutional Investors Weigh In On CME Group

Several institutional investors and hedge funds have recently made changes to their positions in CME. Lake Street Advisors Group LLC increased its holdings in CME Group by 108.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock worth $2,949,000 after buying an additional 6,453 shares during the period. Heartland Bank & Trust Co purchased a new position in shares of CME Group during the first quarter worth $377,000. Unified Investment Management purchased a new position in shares of CME Group during the fourth quarter worth $503,000. Catalyst Capital Advisors LLC lifted its position in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after purchasing an additional 2,636 shares during the period. Finally, OMNI 360 Wealth Inc. purchased a new stake in CME Group in the first quarter valued at $367,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines